Article info
PDFShort report
Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid
- Correspondence to Dr S Piepers, Rudolf Magnus Institute of Neuroscience, Department of Neurology, University Medical Centre Utrecht, The Netherlands HP G 02.320, PO Box 85500, 3508 GA Utrecht, The Netherlands; s.piepers-2{at}umcutrecht.nl
Citation
Quantification of SMN protein in leucocytes from spinal muscular atrophy patients: effects of treatment with valproic acid
Publication history
- Received November 13, 2009
- Revised February 23, 2010
- Accepted March 22, 2010
- First published June 15, 2010.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.